TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer
Authors
Swetha Anandhan•Shelley Herbrich•Padmanee Sharma
Journal
Nature Communications
Published
July 10, 2024
Sign in to comment
Add a comment...